Novian Health begins breast cancer trial
Article Thumbnail ImageApril 12, 2012 -- Novian Health has begun a multicenter clinical trial on the use of its Novilase interstitial laser therapy (ILT) for the destruction of malignant breast tumors, the company said.
Member Sign In:
  MemberID or E-mail Address:

New Members

Becoming a Member is FREE!

  • Real-time radiology-specific news
  • Case of the Day and Teaching Files
  • Focused topics digital communities
  • Lively, discussion groups
  • Medical imaging bookstore
  • SalaryScan
  • Job Boards
  • Online CME
  • Bookstore, market reports, more …
  • Conference Calendar
  • User-controlled eNewsletters
  • … registration is FREE and easy!
  • Novilase ILT is an image-guided, minimally invasive alternative for lumpectomy used to ablate small breast tumors. The new clinical trial is the first stage of a two-stage study as part of a U.S. Food and Drug Administration premarket approval (PMA) process, according to Novian Health.

    Researchers will evaluate the rate of complete tumor ablation of breast cancers that are up to 2 cm, as well as the correlation of the pathology of post­ablation lumpectomy specimens with MRI, mammography, and ultrasound in detecting any residual tumor, the firm said. The first facility to participate in the trial is Rose Breast Center of Denver, CO.

    || About || Advertising || || Bookstore || Breast MRI || Career Center || Case of the Day || Communities || Conferences || Contact Us || ECR News 2014 || Education || Equipment Classifieds || Europe || Facebook || Forums || Home || Links || Marketplace || Middle East || Mobile || Molecular Breast Imaging || New Installations || News in Brief || People in the News || Privacy Policy || RSNA News 2013 || Reference || Salary Survey Results || Trends in Radiology || Twitter || Vendor Connect || Webinars || XML/RSS ||

    Copyright © 2014 All Rights Reserved.